The endothelin signaling pathway (EDN1, EDN3, EDNRB, EDNRA, ECE1) is proposed as the top candidate mechanism via a neural-crest "lineage-balance" model, where a partial mutation biases progenitors toward melanocyte fate (lentigines) at the expense of vascular smooth muscle (cystic medial necrosis).
SINGLE
LEAD
pathophysiologygenetic_factor
| Provider | Stance | Score | Evidence |
| openscientist |
CONCORDANT |
90% |
Endothelin signaling (EDN1, EDN3, EDNRB, EDNRA, ECE1) — supported by six convergent evidence lines (see Section 6).
OpenScientist proposes the endothelin pathway as the strongest candidate mechanism backed by six convergent evidence lines and a lineage-balance model.
PMID:28753427, PMID:15070746
|
| falcon |
SILENT |
— |
Falcon's retrieval never invokes the endothelin pathway; it keeps to the generic neural-crest hypothesis and does not name endothelin genes.
|
Overview
Both providers frame arterial dissection-lentiginosis syndrome as an ultra-rare, case-report-defined familial Mendelian arteriopathy characterized by early arterial dissection, cystic medial necrosis of the arterial wall, and multiple cutaneous lentigines, with an unresolved causal gene and a neural-crest (neurocristopathy) developmental hypothesis as the unifying mechanism.
Agreement
The providers converge on the defining triad (arterial dissection, cystic medial necrosis, lentigines), the neurocristopathy hypothesis linking melanocytes and the neural-crest-derived arterial media, the absence of an identified causal gene or pathogenic variant, the extreme rarity (two families), the childhood onset of lentigines versus later dissection, and the differential diagnosis against other lentiginosis/arteriopathy syndromes.
Divergence
Falcon stays close to the original Schievink 1995 report and reviews, stressing inheritance uncertainty (autosomal recessive suggested but dominant not excluded) and offering no molecular candidate. OpenScientist goes further, asserting autosomal recessive inheritance from OMIM/Orphanet and building a detailed endothelin-pathway "lineage-balance" model (EDN1/EDN3/EDNRB/EDNRA/ECE1) from GWAS, developmental biology, GTEx co-expression, and mouse Ednrb data, plus a general antithrombotic management scheme and a speculative endothelin receptor antagonist option. On epidemiology they differ only mildly: Falcon adds six sporadic cases from reviews that OpenScientist omits. No direct contradictions were found between the two reports.
Integration
Promoted into kb/disorders/Arterial_Dissection_Lentiginosis_Syndrome.yaml: the conservative disease identity and defining triad, the neural-crest/mesenchymal developmental mechanism, cystic medial necrosis as the arterial-wall lesion, the unknown-causal-gene status, the childhood-lentigines/adult-dissection temporal pattern, the ultra-rare two-family epidemiology, and an inheritance entry that captures the provider disagreement (autosomal recessive suggested, dominant not excluded) rather than over-asserting.
Not integrated (leads)
The endothelin-pathway lineage-balance hypothesis, the detailed differential diagnosis, and the broad arterial-dissection management/targeted-therapy literature were retained as research leads rather than curated ADL-specific mechanism or treatment assertions, because they are extrapolated from related pigmentation and vascular systems and not confirmed for this syndrome.
Cross-provider synthesis comparing the falcon (original-report/review-focused) and openscientist (autonomous, endothelin-hypothesis-generating) deep-research reports for arterial dissection-lentiginosis syndrome. best_matching_text values are verbatim excerpts from the two report files; no direct contradictions were found — divergence is coverage/interpretation (inheritance certainty, the endothelin candidate mechanism, sporadic-case counts, and management detail). Literature evidence: blocks and ontology terms are intentionally left to the main curation pipeline on the disorder YAML.